| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/08/2007 | WO2006127893A3 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 03/08/2007 | WO2006127592A3 Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts |
| 03/08/2007 | WO2006125539A3 Combination therapy comprising diaryl ureas for treating diseases |
| 03/08/2007 | WO2006125178A3 Tricyclic pyridazine compounds and their uses as therapeutic agents |
| 03/08/2007 | WO2006124686A3 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 03/08/2007 | WO2006124609A3 Methods and compositions for treating arg |
| 03/08/2007 | WO2006124490A3 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 03/08/2007 | WO2006122012A3 Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
| 03/08/2007 | WO2006121968A3 Method for treatment of uterine fibroid tumors |
| 03/08/2007 | WO2006121552A9 Abuse-resistant amphetamine prodrugs |
| 03/08/2007 | WO2006117307A3 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 03/08/2007 | WO2006117181A3 Prophylaxis and treatment of diseases |
| 03/08/2007 | WO2006111925A3 Inhibition of tumorigenesis by inhibition of a6b4 integrin |
| 03/08/2007 | WO2006111853A3 Stable solid dosage forms of acid labile drug |
| 03/08/2007 | WO2006111624A3 Anti-inflammatory and/or analgesic composition for the intestine comprising branched maltodextrins |
| 03/08/2007 | WO2006110347A3 Single walled carbon nanotubes functionally adsorbed to biopolymers for use as chemical sensors |
| 03/08/2007 | WO2006110175A3 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor |
| 03/08/2007 | WO2006110157A9 Nucleoside phosphonate conjugates as anti hiv agents |
| 03/08/2007 | WO2006108682A3 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents |
| 03/08/2007 | WO2006108572A3 Novel crystalline pharmaceutical product |
| 03/08/2007 | WO2006107411A3 Formulations containing fenofibrate and surfacant mixture |
| 03/08/2007 | WO2006105741A3 Topical pharmaceutical formulation containing nimesulide |
| 03/08/2007 | WO2006105455A3 Methods of treatment utilizing certain melatonin derivatives |
| 03/08/2007 | WO2006103401A3 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 03/08/2007 | WO2006101761A3 Mitotic kinesin inhibitors |
| 03/08/2007 | WO2006098624A3 Anti-viral use of a coumarin agent |
| 03/08/2007 | WO2006086798A3 Compositions and methods involving mda-7 for the treatment of cancer |
| 03/08/2007 | WO2006086617A3 Polyethylene oxide polymers including anti-inflammatory glycodendrons |
| 03/08/2007 | WO2006081127A3 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid |
| 03/08/2007 | WO2006076627A3 Methods and compositions related to modulating the extracellular stem cell environment |
| 03/08/2007 | WO2006075020A3 Ampa antagonist for the treatment of dizziness, including vertigo and meniere's disorder |
| 03/08/2007 | WO2006067392A3 Indole derivatives for the treatment of tuberculosis |
| 03/08/2007 | WO2006054319A3 Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins |
| 03/08/2007 | WO2006037537A3 D-pyranosyl-substituted phenyls, medicaments containing said compounds, use thereof, and method for the production thereof |
| 03/08/2007 | WO2006027579A3 The treatment of inflammatory disorders and pain |
| 03/08/2007 | WO2006023295A3 Pharmaceutical compositions comprising effervescent agents and fenofibrate |
| 03/08/2007 | WO2006020779A3 Targeting chelants and chelates |
| 03/08/2007 | WO2006020145A3 Flt3 inhibitors for immune suppression |
| 03/08/2007 | WO2006017752A8 Sulfated oligosaccharides |
| 03/08/2007 | WO2006012419A3 Inhibition of nf-kb |
| 03/08/2007 | WO2006004880A3 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 03/08/2007 | WO2005115547A3 Myricitrin compounds for sleeping disorders |
| 03/08/2007 | WO2005112933A3 Substituted organosulfur compounds and methods of using thereof |
| 03/08/2007 | WO2005079768A3 Amoxicillin instant granulate |
| 03/08/2007 | WO2005049614A3 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | US20070056049 p53 and VEGF regulate tumor growth of NOS2 expressing cancer cells |
| 03/08/2007 | US20070055246 Spine distraction implant and method |
| 03/08/2007 | US20070055069 Process for the preparation of carvedilol form-ii |
| 03/08/2007 | US20070055065 3-amidinophenylalanine derivatives such as N-(2-aminoethyl)-1-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperidine-4-carboxamide, used as inhibitors of matriptase, for the prophylaxis of tumors |
| 03/08/2007 | US20070055064 Process for the crystallisation of guandinium salts |
| 03/08/2007 | US20070054967 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
| 03/08/2007 | US20070054966 Method for preparing novel transcription factors and use |
| 03/08/2007 | US20070054965 AMPK activating agent |
| 03/08/2007 | US20070054964 Topical formulations containing O-Desmethyl Venlafaxine (ODV) or its salts |
| 03/08/2007 | US20070054963 Dissolving Cinacalcet HCl in chloroform; mixing an aliphatic or cyclic hydrocarbon nonsolvent to obtain a precipitate; and drying under reduced pressure at greater than 25 degrees C. |
| 03/08/2007 | US20070054962 Method for treating acute or chronic pain |
| 03/08/2007 | US20070054961 Factor |
| 03/08/2007 | US20070054960 Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride form II |
| 03/08/2007 | US20070054959 Dichloric acids, reactive chlorine compounds, their derivatives, anions and salts, as well as processes for their manufacture and use |
| 03/08/2007 | US20070054958 Compounds for treatment of lipase-mediated diseases |
| 03/08/2007 | US20070054957 Stable oxaliplatin formulation |
| 03/08/2007 | US20070054956 6-(4-Methoxy-phenyl)-5-{4-[4-(4,4,5,5,5-pentafluoropentylsulfanyl/ pentafluoropentanesulfinyl)-butoxy]-phenoxy}-naphthalen-2-ol; anticarcinogenic agent; breast cancer, metastases to the bone or brain, radiation fibrosis and neutropenic sepsis |
| 03/08/2007 | US20070054954 Method of manufacturing glimepiride and the respective intermediate |
| 03/08/2007 | US20070054953 A novel process for preparation of indole derivatives |
| 03/08/2007 | US20070054952 Comprising etodolac as a Non-Steroidal Anti-Inflammatory Drug and lidocaine; inhibiting cyclooxygenase; good in skin permeability, and penetratability and diffusivity; plaster |
| 03/08/2007 | US20070054951 Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054949 Hypertension and dyslipidemia combination therapy using compounds that are both Angiotensin II 1 receptor antagonists, and activators of peroxisome proliferator activated receptors (PPARs), and antilipemic agents such as statins; telmisartan and simvastatin for example |
| 03/08/2007 | US20070054948 Purification of olmesartan medoxomil |
| 03/08/2007 | US20070054947 Pharmaceutical composition comprising valsartan |
| 03/08/2007 | US20070054946 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 03/08/2007 | US20070054945 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 03/08/2007 | US20070054944 Pharmaceutical compositions comprising 1-isopropyl-3-[ (4-M-toluidino-3-pyridyl) sulphonyl] -urea as active ingredient |
| 03/08/2007 | US20070054943 Therapeutic agent for keratoconjunctival disorder |
| 03/08/2007 | US20070054942 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases |
| 03/08/2007 | US20070054941 Removal of aldehyde impurity by reactive polystyrene resini |
| 03/08/2007 | US20070054940 Remedy for down's syndrome |
| 03/08/2007 | US20070054939 N-ethyl-N-(1-methyl-2-oxo-2-phenylethyl)2-[1(4'-trifluoromethylbiphenyl-2-carbonyl)piperid-4-yl]thiazole-4-carbamate ; hypertriglyceridaemia, hypercholesterolaemia, or dyslipidaemia associated with diabetes; microsomal triglyceride transfer protein (MTP), |
| 03/08/2007 | US20070054938 Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides |
| 03/08/2007 | US20070054937 Method of treating or inhibiting the development of brain inflammation and sepsis |
| 03/08/2007 | US20070054936 such as 4-(5-formyl-2-methoxy-phenyl)-7-trifluoromethyl-quinoline-3-carboxylic acid ethyl ester; urinary incontinence, overactive bladder, hypertension, erectile dysfunction, benign prostate hyperplasia, female sexual disorders, premature labor, dysmenorrhea, irritable bowl syndrome, airway hyperactivity |
| 03/08/2007 | US20070054935 Novel pyridine derivatives as potassium ion channel openers |
| 03/08/2007 | US20070054934 Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent |
| 03/08/2007 | US20070054933 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/08/2007 | US20070054932 Inhibitors of ABC drug transporters at the blood-brain barrier |
| 03/08/2007 | US20070054931 Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof |
| 03/08/2007 | US20070054930 CXCR4 antagonists for the treatment of medical disorders |
| 03/08/2007 | US20070054929 2-Substituted pyrimidines |
| 03/08/2007 | US20070054928 c-Met modulators and methods of use |
| 03/08/2007 | US20070054925 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/08/2007 | US20070054924 Novel piperidines as chemokine modulators (ccr) |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054921 Substituted indoles and a process for preparing substituted indoles |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054919 chemokine receptor antagonists used for the therapy of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, ophthalmic inflammation, diabetes, meningitis, tumors and side effect reduction |
| 03/08/2007 | US20070054918 N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/08/2007 | US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 03/08/2007 | US20070054916 Aryl nitrogen-containing bicyclic compounds and methods of use |